• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

International Isotopes shuffles management team

Article

Following the retirement of chairman and treasurer Ira Lon Morgan, radiopharmaceutical manufacturer International Isotopes has made some additional changes to its senior management team (SCAN 12/15/99). The Denton, TX-based company, which is in

Following the retirement of chairman and treasurer Ira Lon Morgan, radiopharmaceutical manufacturer International Isotopes has made some additional changes to its senior management team (SCAN 12/15/99). The Denton, TX-based company, which is in the process of transitioning to fully commercial operations, announced that newly appointed CEO David Camp has taken on the additional responsibilities of president. Camp replaces former president Carl Seidel, who has left the company.

In addition, Bryce Drake has joined International Isotopes as director of support services. Drake takes over the position from George Butterworth, who has stepped into the new position of director of radioisotope production. Also new to the management team is Scott Colpitts, who has replaced Gaylord King as director of radiopharmaceutical manufacturing. King will continue to work closely with the firm.

In other company news, the Bureau of Radiation Control of the Texas Department of Health approved amendments to International Isotopes’ operational and development licenses that will allow the company to produce commercial quantities of radioisotopes for use in nuclear medicine procedures.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.